These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9959)

  • 1. Work performance versus clinical assessment in the evaluation of phenothiazine therapy.
    Harper P; Chacon C
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):50-5. PubMed ID: 9959
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and work performance variables in phenothiazine therapy of schizophrenia.
    Chacon C; Harper P
    Acta Psychiatr Scand; 1973; 49(1):65-76. PubMed ID: 4572169
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.
    Jain RC; Ananth JV; Lehmann HE; Ban TA
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):585-9. PubMed ID: 241609
    [No Abstract]   [Full Text] [Related]  

  • 6. Work study in the assessment of the effects of phenothiazines in schizophrenia.
    Chacon C; Harper P; Harvey GF
    Compr Psychiatry; 1972; 13(6):549-54. PubMed ID: 4404679
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintenance therapy and schizophrenia.
    Leff JP
    Br J Psychiatry; 1975; Spec No 9():55-8. PubMed ID: 241453
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
    Dencker SJ; Frankenberg K; Malm U; Zell B
    Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
    [No Abstract]   [Full Text] [Related]  

  • 9. Piperacetazine and chlorpromazine: a comparison.
    Johnson AC; Kulkarni AS
    Am J Psychiatry; 1973 May; 130(5):603-5. PubMed ID: 4144711
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine enanthate.
    Ahlfors UG
    Acta Psychiatr Scand Suppl; 1973; 241():95-9. PubMed ID: 4147516
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatment in newly admitted schizophrenic patients.
    Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
    Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
    [No Abstract]   [Full Text] [Related]  

  • 12. AMDP psychopathology factors in chronic schizophrenia: a clinical trial of two long-acting neuroleptics.
    Lapierre YD; von Frenckell R
    Mod Probl Pharmacopsychiatry; 1983; 20():193-203. PubMed ID: 6137766
    [No Abstract]   [Full Text] [Related]  

  • 13. Low dose medication strategies in the maintenance treatment of schizophrenia.
    Kane JM
    Schizophr Bull; 1983; 9(4):528-32. PubMed ID: 6140751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of butaclamol in chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    J Clin Pharmacol; 1977; 17(8-9):529-36. PubMed ID: 19510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of four evaluation criteria in a clinical trial with schizophrenic patients.
    Fombonne E; Peron-Magnan P; Fuhrer R; Simon P
    Neuropsychobiology; 1986; 16(4):186-92. PubMed ID: 2886952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting phenothiazine and social therapy in the community treatment of acute schizophrenics.
    Goldstein MJ; Rodnick EH; Evans JR; May PR
    Psychopharmacol Bull; 1975 Oct; 11(4):37-8. PubMed ID: 715
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical symptomatology and drug compliance in schizophrenic patients.
    Bartkó G; Herczeg I; Zádor G
    Acta Psychiatr Scand; 1988 Jan; 77(1):74-6. PubMed ID: 2894746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.